New scan could spot cancer spread sooner, boosting survival

NCT ID NCT06877949

Recruiting now Knowledge-focused Sponsor: Odense University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two types of scans—FDG-PET/CT and standard CT—to see which one better tracks breast cancer that has spread. Researchers want to know if the newer scan can find cancer growth earlier, helping doctors start new treatments sooner and potentially extend patients' lives. About 420 adults with newly diagnosed metastatic breast cancer will be randomly assigned to one scan type and followed over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma breast neoplasm Disease Progression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC BREAST CANCER RESPONSE MONITORING

Contacts and locations

Locations

Aalborg University Hospital
RECRUITING

Aalborg, 9000, Denmark
Aarhus University Hospital
RECRUITING

Aarhus, 8200, Denmark
Esbjerg and Grindsted Hospital
RECRUITING

Esbjerg, 6700, Denmark
Herlev and Gentofte Hospital
RECRUITING

Herlev, 2730, Denmark
Hospital of Southern Jutland
RECRUITING

Sønderborg, 6400, Denmark
Humanitas Research Hospital
NOT_YET_RECRUITING

Milan, 20089, Italy
Irccs Azienda Ospedaliero - Universitario Di Bologna
RECRUITING

Bologna, 40138, Italy
Klinikum Der Technischen Universität München
NOT_YET_RECRUITING

München, 81675, Germany
Lille Baelt Hospital
RECRUITING

Vejle, 7100, Denmark
Odense University Hospital
RECRUITING

Odense, 5000, Denmark
Rigshospitalet
RECRUITING

Copenhagen, 2100, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.